Literature DB >> 24403290

Luteolin nanoparticle in chemoprevention: in vitro and in vivo anticancer activity.

Debatosh Majumdar1, Kyung-Ho Jung, Hongzheng Zhang, Sreenivas Nannapaneni, Xu Wang, A R M Ruhul Amin, Zhengjia Chen, Zhuo G Chen, Dong M Shin.   

Abstract

Cancer prevention (chemoprevention) by using naturally occurring dietary agents has gained immense interest because of the broad safety window of these compounds. However, many of these compounds are hydrophobic and poorly soluble in water. They frequently display low bioavailability, poor systemic delivery, and low efficacy. To circumvent this problem, we explored a novel approach toward chemoprevention using nanotechnology to deliver luteolin, a natural compound present in green vegetables. We formulated water-soluble polymer-encapsulated Nano-Luteolin from hydrophobic luteolin, and studied its anticancer activity against lung cancer and head and neck cancer. In vitro studies demonstrated that, like luteolin, Nano-Luteolin inhibited the growth of lung cancer cells (H292 cell line) and squamous cell carcinoma of head and neck (SCCHN) cells (Tu212 cell line). In Tu212 cells, the IC50 value of Nano-Luteolin was 4.13 μmol/L, and that of luteolin was 6.96 μmol/L. In H292 cells, the IC50 of luteolin was 15.56 μmol/L, and Nano-Luteolin was 14.96 μmol/L. In vivo studies using a tumor xenograft mouse model demonstrated that Nano-Luteolin has a significant inhibitory effect on the tumor growth of SCCHN in comparison to luteolin. Our results suggest that nanoparticle delivery of naturally occurring dietary agents like luteolin has many advantages and may have potential application in chemoprevention in clinical settings. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24403290      PMCID: PMC3888883          DOI: 10.1158/1940-6207.CAPR-13-0230

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  58 in total

Review 1.  Small-scale systems for in vivo drug delivery.

Authors:  David A LaVan; Terry McGuire; Robert Langer
Journal:  Nat Biotechnol       Date:  2003-10       Impact factor: 54.908

2.  Proteomic analysis reveals ATP-dependent steps and chaperones involvement in luteolin-induced lung cancer CH27 cell apoptosis.

Authors:  Hong-Zin Lee; Wen-Hui Yang; Bo-Ying Bao; Pei-Ling Lo
Journal:  Eur J Pharmacol       Date:  2010-06-08       Impact factor: 4.432

3.  Nanomedicine: nanocarriers shape up for long life.

Authors:  Nobuhiro Nishiyama
Journal:  Nat Nanotechnol       Date:  2007-04       Impact factor: 39.213

Review 4.  Nanoparticle delivery of cancer drugs.

Authors:  Andrew Z Wang; Robert Langer; Omid C Farokhzad
Journal:  Annu Rev Med       Date:  2011-09-01       Impact factor: 13.739

5.  Luteolin induces G1 arrest in human nasopharyngeal carcinoma cells via the Akt-GSK-3β-Cyclin D1 pathway.

Authors:  Chye-Sun Ong; Jing Zhou; Choon-Nam Ong; Han-Ming Shen
Journal:  Cancer Lett       Date:  2010-07-23       Impact factor: 8.679

6.  Protective role of luteolin in 1,2-dimethylhydrazine induced experimental colon carcinogenesis.

Authors:  V Manju; N Nalini
Journal:  Cell Biochem Funct       Date:  2007 Mar-Apr       Impact factor: 3.685

7.  Enhanced anti-tumor activity by the combination of the natural compounds (-)-epigallocatechin-3-gallate and luteolin: potential role of p53.

Authors:  A R M Ruhul Amin; Dongsheng Wang; Hongzheng Zhang; Shifang Peng; Hyung Ju C Shin; Johann C Brandes; Mourad Tighiouart; Fadlo R Khuri; Zhuo Georgia Chen; Dong M Shin
Journal:  J Biol Chem       Date:  2010-09-08       Impact factor: 5.157

8.  Downregulation of androgen receptor expression by luteolin causes inhibition of cell proliferation and induction of apoptosis in human prostate cancer cells and xenografts.

Authors:  Feng-Lan Chiu; Jen-Kun Lin
Journal:  Prostate       Date:  2008-01-01       Impact factor: 4.104

9.  Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate.

Authors:  Imtiaz A Siddiqui; Vaqar M Adhami; Dhruba J Bharali; Bilal B Hafeez; Mohammad Asim; Sabih I Khwaja; Nihal Ahmad; Huadong Cui; Shaker A Mousa; Hasan Mukhtar
Journal:  Cancer Res       Date:  2009-02-17       Impact factor: 12.701

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  36 in total

Review 1.  Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.

Authors:  A R M Ruhul Amin; Phillip A Karpowicz; Thomas E Carey; Jack Arbiser; Rita Nahta; Zhuo G Chen; Jin-Tang Dong; Omer Kucuk; Gazala N Khan; Gloria S Huang; Shijun Mi; Ho-Young Lee; Joerg Reichrath; Kanya Honoki; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; W Nicol Keith; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Hiromasa Fujii; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang; Alan Bilsland; Dong M Shin
Journal:  Semin Cancer Biol       Date:  2015-03-06       Impact factor: 15.707

Review 2.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

3.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

Review 4.  Investigating Polyphenol Nanoformulations for Therapeutic Targets against Diabetes Mellitus.

Authors:  Fahadul Islam; Jannatul Fardous Khadija; Md Rezaul Islam; Sheikh Shohag; Saikat Mitra; Saad Alghamdi; Ahmad O Babalghith; Abdulrahman Theyab; Mohammad Tauhidur Rahman; Aklima Akter; Abdullah Al Mamun; Fahad A Alhumaydhi; Talha Bin Emran
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-21       Impact factor: 2.650

Review 5.  Plant-Derived Natural Products in Cancer Research: Extraction, Mechanism of Action, and Drug Formulation.

Authors:  Wamidh H Talib; Izzeddin Alsalahat; Safa Daoud; Reem Fawaz Abutayeh; Asma Ismail Mahmod
Journal:  Molecules       Date:  2020-11-14       Impact factor: 4.411

Review 6.  Pharmacokinetics of nanotechnology-based formulations in pediatric populations.

Authors:  Venkata K Yellepeddi; Andrea Joseph; Elizabeth Nance
Journal:  Adv Drug Deliv Rev       Date:  2019-09-05       Impact factor: 15.470

Review 7.  A Review of Promising Natural Chemopreventive Agents for Head and Neck Cancer.

Authors:  Kyle Crooker; Rana Aliani; Megha Ananth; Levi Arnold; Shrikant Anant; Sufi Mary Thomas
Journal:  Cancer Prev Res (Phila)       Date:  2018-03-30

Review 8.  Anticancer activity of flavonoids accompanied by redox state modulation and the potential for a chemotherapeutic strategy.

Authors:  Yongkyu Lee; Jehyung Lee; Changbaek Lim
Journal:  Food Sci Biotechnol       Date:  2021-03-20       Impact factor: 2.391

9.  DPYD, down-regulated by the potentially chemopreventive agent luteolin, interacts with STAT3 in pancreatic cancer.

Authors:  Hiroyuki Kato; Aya Naiki-Ito; Shugo Suzuki; Shingo Inaguma; Masayuki Komura; Kenju Nakao; Taku Naiki; Kenta Kachi; Akihisa Kato; Yoichi Matsuo; Satoru Takahashi
Journal:  Carcinogenesis       Date:  2021-07-16       Impact factor: 4.944

Review 10.  Polymeric and Lipid Nanoparticles: Which Applications in Pediatrics?

Authors:  Noelia Nieto González; Antonella Obinu; Giovanna Rassu; Paolo Giunchedi; Elisabetta Gavini
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.